Snakebite Prognostic Factors: Leading Factors of Weak Therapeutic Response Following Snakebite Envenomation

سال انتشار: 1391
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 381

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_PJMT-1-1_006

تاریخ نمایه سازی: 23 مهر 1398

چکیده مقاله:

Background: The goal of antivenom administration for snake-bitten patients is to achieve therapeutic response (initial control), which means reversal of the venom-induced effects through neutralizing the venom. The aim of this study was to identify snakebite prognostic factors of weak therapeutic response prior to antivenom administration. Methods: This was a retrospective study of patients with viperidae snakebite envenomation who were admitted to Mashhad Toxicology Centre during 2007-2011. Demographic features, clinical manifestations and snakebite severity score (SSS) were collected prior to antivenom administration. Total number of antivenom vials administered to achieve therapeutic response and duration of hospitalization were also recorded. Potential factors in snakebite prognosis were analyzed by comparing in two groups of achieving therapeutic response with less than 5 vials and over 5 to calculate odds ratio.  Results: Total of 108 patients (male/female: 85/23) with mean (SD) age of 34.5 (17.0) were studied. The most common manifestations included fang marks (100%), pain (100%), ecchymosis (89%), swelling (83%), blister formation (48%) and thrombocytopenia (25%). In univariate analysis, thrombocytopenia (P=0.01), spontaneous bleeding (P=0.02), coagulopathic disturbances (P=0.007), swelling (P=0.003), progressive swelling (P=0.005), ecchymosis (P=0.05) and respiratory distress (P= 0.05) were significantly correlated to weak therapeutic response. Swelling and spontaneous bleeding were the strongest snakebite prognostic factors, as respectively they put the patients at 12.4 and 10.4 fold risks for difficult achievement of therapeutic response. Conclusions: In snakebite, some clinical manifestations in the first hours of admission and prior to antivenom administration are associated with weak therapeutic response. Identifying these prognostic factors, can assist health care providers to better estimate the patient’s needs and predict the final consequences. 

نویسندگان

Bita Dadpour

Addiction Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran

Azam Shafahi

Department of infectious diseases, Intensive care unit, Mashhad University of Medical Sciences, Mashhad, Iran

Seyed Monzavi

Addiction Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran. AJA University of Medical Sciences, Tehran, Iran

Abbas Zavar

Addiction Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Ministry of Health and Medical Education. National Report of Envenomation. ...
  • Afshari R, Majdzadeh R, Balali-Mood M. Pattern of acute poisonings ...
  • Afshari R, Monzavi SM. Venomous animals and insects Envenomations. In: ...
  • Warrell DA. Venomous bites, stings, and poisoning. Infect Dis Clin ...
  • Gold BS, Dart RC, Barish RA. Bites of venomous snakes. ...
  • Razi vaccine and serum research institute (RVSRI). Razi™ Polyvalent Snake ...
  • Theakston RD, Warrell DA. Antivenoms: a list of hyperimmune sera ...
  • Srimannarayana J, Dutta TK, Sahai A, Badrinath S. Rational use ...
  • Dart RC, Hurlbut KM, Garcia R, Boren J. Validation of ...
  • Isbister GK. Snakebite doesn t cause disseminated intravascular coagulation: coagulopathy ...
  • World health organization Regional Office for South-East Asia. WHO/SEARO Guidelines ...
  • Frangides CY, Koulouras V, Kouni SN, et al. Snake venom ...
  • Lavonas EJ, Ruha AM, Banner W, et al. Unified treatment ...
  • United States: results of an evidence-informed consensus workshop. BMC Emerg ...
  • Yin S, Kokko J, Lavonas E, Mlynarchek S, Bogdan G, ...
  • Kleiman NS, Freedman JE, Tracy PB, et al. Platelets: developmental ...
  • White J. Snake venoms and coagulopathy. Toxicon 2005 Jun 15; ...
  • Schmaier AH, Claypool W, Colman RW. Crotalocytin: recognition and purification ...
  • Gutiérrez JM, Escalante T, Rucavado A. Experimental pathophysiology of systemic ...
  • Schmaier AH, Claypool W, Colman RW. Crotalocytin: recognition and purification ...
  • Boyer LV, Seifert SA, Clark RF, et al. Recurrent and ...
  • Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin ...
  • Bond RG, Burkhart KK. Thrombocytopenia following timber rattlesnake envenomation. Ann ...
  • Odeleye AA, Presley AE, Passwater ME, Mintz PD. Report of ...
  • Otero-Patiño R. Epidemiological, clinical and therapeutic aspects of Bothrops asper ...
  • Chippaux JP, Williams V, White J. Snake venom variability: methods ...
  • نمایش کامل مراجع